Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2022-03-21

Original market date: See footnote 1

2011-12-16

Lot number: See footnote 2

SST1301

Expiry date: See footnote 2

2015-03-31

Product name:

SENNOSIDES WITH DOCUSATE SODIUM

Description:

FILM-COATED TABLET

DIN:

02362708 Electronic product monograph is not available

Company:

EURO-PHARM INTERNATIONAL CANADA INC
9400 Boul. Langelier
Montreal
Quebec
Canada H1P 3H8

Class:

Human

Dosage form(s):

Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

2

Schedule(s):

OTC

 

American Hospital Formulary Service (AHFS): See footnote 3

56:12.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

A06AB56 SENNA GLYCOSIDES, COMBINATIONS

Active ingredient group (AIG) number:See footnote5

0215780001

List of active ingredient(s)
Active ingredient(s) Strength
DOCUSATE SODIUM 50 MG
SENNOSIDES 8.6 MG
Version 4.0.2
Date modified: